In this video, Teiko's Associate Director of Commercial Strategy, Jolien Sweere, reviews our approach to unsupervised clustering by highlighting an example from our with the Parker Institute for Cancer Immunotherapy where we used mass cytometry to analyze urothelial carcinoma patient samples from their RADIOHEAD study.
.png)
